Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

2.42
Delayed Data
As of Aug 18
 -0.02 / -0.82%
Today’s Change
1.65
Today|||52-Week Range
5.70
+39.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash98.1M104.2M155.4M182.5M
 
 
 
 
 
Short Term Investment Cash19.8M6.1M51.2M-62.9M
 
 
 
 
 
Cash & Short Term Investments177.0M205.5M214.0M194.0M
 
 
 
 
 
 
ReceivablesReceivables0.002.6M6.8M1.1M
 
 
 
 
 
InventoriesInventories0.001.2M10.8M23.2M
 
 
 
 
 
Current AssetsOther Current Assets1.3M2.0M2.3M6.2M
 
 
 
 
 
Current Assets178.3M211.3M233.9M224.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.6M2.9M3.5M3.7M
 
 
 
 
 
Depreciation-1.9M-2.1M-2.2M-2.6M
 
 
 
 
 
Intangible Assets0.00----76.1M
 
 
Other Assets1.0M621.0K1.3M78.9M
 
 
 
 
 
Total Assets180.1M213.0M236.6M304.6M
 
 
 
 
 
 
LiabilitiesAccounts Payable4.8M4.2M6.5M15.2M
 
 
 
 
 
Accrued Expenses9.9M12.6M10.4M12.9M
 
 
 
 
 
Other Current Liabilities13.3M20.8M20.3M42.8M
 
 
 
 
 
Other Liabilities22.9M29.7M32.2M65.4M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt80.0M83.9M88.1M166.2M
 
 
 
 
 
Deferred Taxes0.00-547.0K0.000.00
 
 
Other Liabilities232.0K354.0K150.0K0.00
 
 
 
 
Total Liabilities138.3M190.6M203.2M244.2M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.003.3M
 
 
Common Equity41.9M22.3M33.4M57.0M
 
 
 
 
 
Total Shareholder Equity41.9M22.3M33.4M60.4M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding10.5M12.3M14.6M14.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.